ELA-32(human) TFA Catalog No.:M16934-C Smiles: [2H]C([2H])([2H])C(NCC(O)C1C=C(Cl)C(N)=C(C=1)C(F)(F)F)(C([2H])([2H])[2H])C([2H])([2H])[2H]

Smiles: [2H]C([2H])([2H])C(NCC(O)C1C=C(Cl)C(N)=C(C=1)C(F)(F)F)(C([2H])([2H])[2H])C([2H])([2H])[2H]

In KARPAS-422 cells

NCCCC[C@H](N[C@@H](CCC1C=CC=CC=1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O

Smiles: N[C@@H](CC(O)=O)C(O)=O

Domenici L

ELA-32(human) TFA Catalog No.:M16934-C Smiles: [2H]C([2H])([2H])C(NCC(O)C1C=C(Cl)C(N)=C(C=1)C(F)(F)F)(C([2H])([2H])[2H])C([2H])([2H])[2H]ELA 32(human) TFA is a potent, high affinity apelin receptor agonist (IC50=0. 27 nM; Kd=0. 51 nM). ELA 32(human) TFA exhibits no binding GPR15 and GPR25. ELA 32(human) TFA activates the PI3K AKT pathway and promotes self renewal of hESCs via cell cycle progression and protein translation. ELA 32(human) TFA also potentiates the TGF pathway, priming hESCs toward the endoderm lineage. ELA 32(human) TFA stimulates angiogenesis in HUVEC cells. Product